The data suggest that PB, which inhibits the PI3K/Akt/mTOR signaling pathway in MCF‐7 breast cancer cells, is unlikely to interfere with HIF‐1α signaling or its target genes; however, PB may reduce HIF‐1α through an alternative mechanism. Here, HIF1A is linked to breast carcinoma.